Latisse During Pregnancy – Is It Safe?

Last Updated On: June 24, 2024

According to recent studies, many pregnant women continue their skincare routines to address common concerns like acne, stretch marks, and dry skin. This attention to skincare highlights the importance of understanding which products are safe during pregnancy.

One such product that often comes into question is Latisse, a popular eyelash growth treatment. Latisse contains bimatoprost, an ingredient that enhances eyelash length and thickness but is classified by the FDA as pregnancy category “C”. This classification indicates potential risks to the fetus, making it crucial for expecting mothers to know whether they can safely use this product.

In this article, we will explore Latisse’s safety for pregnant women, examine potential risks, and provide guidance on maintaining a safe and effective skincare routine during pregnancy.

Key Takeaways

• Latisse, a popular eyelash growth serum, contains bimatoprost as its active ingredient.
• Current research on the safety of using Latisse during pregnancy is limited.
• Bimatoprost has been associated with potential risks to pregnant women and fetal development.
• Medical experts and leading organizations recommend avoiding the use of Latisse during pregnancy due to these potential risks.

About: Operating since 2016, Med Supply Solutions is known for being one of the industry’s top and trusted suppliers of cosmetic and viscosupplementation products. If you’re looking to, buy Latisse online contact our sales department for more information.

Understanding Latisse and Its Active Ingredient

Latisse, an FDA-approved treatment, uses bimatoprost to enhance eyelash growth, increasing length, thickness, and darkness. Its unique FDA approval sets a benchmark for safety and efficacy. Bimatoprost is Latisse’s active ingredient, promoting longer, thicker, and darker eyelashes. Its application follows specific dosage guidance to ensure optimal results with minimal side effects. 

However, its use during pregnancy raises concerns due to potential risks to fetal development. Classified by the FDA as pregnancy class “C”, caution remains paramount when considering treatments involving bimatoprost for lash or eyebrow enhancement in such sensitive periods.

Latisse Safety and Pregnancy

Pregnant women often question the safety of using Latisse for eyelash growth. Doctors carefully evaluate the risks and benefits before recommending it during pregnancy. Current research suggests Latisse, a popular eyelash serum, requires caution during pregnancy. 

Latisse reflects concerns about potential impacts on the fetus due to its active ingredient, bimatoprost. Studies have yet to establish safety for pregnant or breastfeeding individuals, underscoring the importance of medical consultation before use. Given the lack of definitive data, health professionals recommend discontinuing Latisse during pregnancy.

Effects of Bimatoprost on Pregnant Women

Bimatoprost carries potential risks during pregnancy that cannot be ignored. It suggests the possibility of adverse effects on pregnant women and their unborn babies. Studies in animals have shown adverse outcomes, leading healthcare professionals to urge caution. 

Pregnant women are advised against using Latisse due to the lack of conclusive safety data ensuring no harm to fetal development. Latisse should not be used during pregnancy unless the benefit outweighs the risk to the fetus. Despite its benefits for eyelash growth and treating hypopigmentation, medical experts recommend discontinuing Latisse usage if a woman becomes pregnant. 

This precaution stems from insufficient information about its safety during this critical time. Given these concerns, it’s crucial for those considering or currently using Latisse for cosmetic reasons or orbital fat loss management to consult with their healthcare providers before continuing treatment while expecting.

Potential Risks and Contraindications

Using Latisse during pregnancy introduces various potential risks that demand careful consideration. Pregnant women should cautiously consider the possible risks of using Latisse due to its active ingredient, bimatoprost, which the FDA classified as pregnancy category “C”, suggesting a risk cannot be ruled out. 

Animal studies have highlighted negative impacts on pregnancy and fetal development, raising concerns about similar effects in humans. Given these uncertainties and the lack of established safety profiles for pregnant or breastfeeding individuals, medical professionals often advise discontinuing Latisse during pregnancy. 

Understanding that bimatoprost might contribute to conditions such as orbital fat loss or hypopigmentation adds another layer of caution. Healthcare professionals are key in guiding patients through these considerations, ensuring they are informed about possible contraindications for Latisse use during this sensitive period.

Guidelines and Recommendations for Latisse Use During Pregnancy

Experts strongly advise against using Latisse during pregnancy, as its active ingredient, bimatoprost, falls under the FDA’s pregnancy classification “C.” Medical professionals underscore that the safety of Latisse for pregnant women or those who are breastfeeding remains unclear. This stance emerges from limited studies and concerns about bimatoprost’s effects on fetal health.

Many healthcare providers emphasize consultation before considering Latisse during pregnancy. They highlight crucial points, such as the absence of established safety data regarding Latisse’s long-term side effects, orbital fat loss, hypopigmentation, and dosage adjustments in pregnant individuals.

As animal studies have hinted at negative impacts on pregnancy from bimatoprost exposure, experts recommend erring on the side of caution and discontinuing its use until after pregnancy and breastfeeding periods conclude.

Recommendations from Leading Medical Organizations

Medical professionals must consult leading medical organizations before prescribing Latisse during pregnancy. These entities provide guidelines that help ensure patient safety and reduce potential risks.

• FDA: Latisse, classified as pregnancy class “C”, demands careful benefit-risk assessment before prescribing to pregnant women.
• ACOG: Advises against cosmetic treatments like Latisse lacking safety data during pregnancy due to unknown fetal effects.
• Keloid Susceptibility: Considered in patients due to lack of safety data for Latisse use in such cases.
• AAD: Caution with Latisse during pregnancy due to unexplored risks like orbital fat loss or hypopigmentation.
• Healthcare Providers: Suggest less risky alternatives for pregnant women, preventing harm to the fetus.
• Guidelines: Detailed counseling on Bimatoprost’s risks during pregnancy, especially in the first 12 weeks.
• Breastfeeding: Pediatric associations recommend avoiding Latisse due to unknown safety in breast milk.
• Consultation: It is essential to talk with experienced healthcare professionals before adjusting Latisse dosage or starting treatment during pregnancy or lactation.

Conclusion

Using Latisse during pregnancy comes with its risks and uncertainties. The drug’s active ingredient, Bimatoprost, carries potential hazards to both pregnant women and their developing fetuses.

Guidelines from medical organizations suggest avoiding Latisse while pregnant due to the lack of established safety data. Expectant mothers must discuss all medication use with their healthcare providers, including cosmetic treatments like Latisse.

Safety should always be the top priority in these situations, ensuring that both mother and child remain healthy throughout the pregnancy.

FAQs

1. Can I use Latisse when I am pregnant?

It’s best to avoid using Latisse during pregnancy due to unclear safety for unborn babies.

2. What are the long-term side effects of using Latisse?

Long-term side effects of Latisse may include orbital fat loss and hypopigmentation.

3. Does Latisse cause any changes to eye or skin color?

Latisse may cause hypopigmentation, lightening the skin around your eyes.

4. Should I worry about losing fat around my eyes if I use Latisse for a long time?

Long-term use of Latisse might lead to orbital fat loss, changing the appearance of the eye area.

References

Is Latisse Safe During Pregnancy? www.thebump.com. Published February 28, 2017. Accessed May 23, 2024. https://www.thebump.com/a/latisse-safe-during-pregnancy 

Bimatoprost topical (Latisse) Use During Pregnancy. Drugs.com. Accessed May 23, 2024. https://www.drugs.com/pregnancy/bimatoprost-topical.html